- WebinarOntario’s overdose epidemic continues to threaten people who use drugs and their families and communities. It has also been worsened by the COVID-19 pandemic and the homelessness crisis.
- WebinarPeer navigation is a promising approach for supportive HIV and hepatitis C care. There is an emerging need for Indigenous-centred models of peer navigation.
- In late 2019 a new coronavirus called SARS-CoV-2 appeared in East Asia and rapidly spread around the world. In some people this virus causes an illness called Coronavirus Disease-2019 (COVID-19) that…
- Clinical trials of the Pfizer-BioNTech vaccine have found that it is generally safe. Local side effects (at the injection site) included pain, swelling and redness. Local and systemic side effects (…
- Clinical trials of the Moderna vaccine have found that it is generally safe. Local side effects (at the injection site) included pain, swelling and redness. Local and systemic side effects (including…
- There have been reports of relatively rare serious allergic reactions to both the Pfizer-BioNTech and Moderna mRNA-based vaccines. Readers should bear in mind that while these reports can be alarming…
- Interim CDC analysis of severe allergic reactions in people who received the Pfizer-BioNTech vaccineAnaphylaxis is a serious allergic reaction that can become life threatening. Here are key points about anaphylaxis from the U.S. Centers for Disease Control and Prevention (CDC):
“… - Anaphylaxis is a serious allergic reaction that can become life threatening. Here are key points about anaphylaxis from the U.S. Centers for Disease Control and Prevention (CDC):
“… - The Centers for Disease Control and Prevention (CDC) has extensive guidance about the rollout of the COVID vaccine program. A summary of the CDC’s advice to vaccination sites is as follows:
- The vaccines previously reported on in this issue of TreatmentUpdate use messenger RNA. However, for its COVID-19 vaccine, the Janssen corporation is using a modified form of a virus called an…
- As this issue of TreatmentUpdate went to press, the Janssen corporation released the interim data from its phase III clinical trial.